Spyre Therapeutics (SYRE) Payables (2015 - 2026)
Spyre Therapeutics' Payables came in at $5.72 million for Q2 2026, up 54.1% from $3.71 million a year earlier and up 0.5% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Payables (2015 - 2026) Analysis & Trends
At the end of FY2025, Spyre Therapeutics' Payables was $8.9 million.
- Payables carries a five-year compound annual growth rate of 31.6% (FY2020 to FY2025).
- Going back by year, Payables was $666,000 in FY2024 (-25.7%), $896,000 in FY2023 (+32.3%), $677,000 in FY2022 (-79.6%) and $3.32 million in FY2021 (+47.2%).
- The five-year range for quarterly Payables is $666,000 (Q4 2024) to $8.9 million (Q4 2025).
- Year-over-year, Payables increased in six of the last seven quarters, with growth averaging 52.7%.
- The fastest year-over-year change in Payables over five years came in Q3 2024 (growth of 207.8%), and the weakest in Q4 2022 (a decline of 79.6%).
- Business Quant data shows SYRE's Payables at $5.69 million (Q1 2026), $8.9 million (Q4 2025) and $7.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Spyre Therapeutics | 7.84 Bn | 7.84 Bn | - | 5.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.72 Mn |
| Mar 31, 2026 | 5.69 Mn |
| Dec 31, 2025 | 8.90 Mn |
| Sep 30, 2025 | 7.46 Mn |
| Jun 30, 2025 | 3.71 Mn |
| Mar 31, 2025 | 3.69 Mn |
| Dec 31, 2024 | 666,000.00 |
| Sep 30, 2024 | 5.17 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Mar 31, 2024 | 3.11 Mn |
| Dec 31, 2023 | 896,000.00 |
| Sep 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 2.85 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 677,000.00 |
| Sep 30, 2022 | 4.18 Mn |
| Jun 30, 2022 | 1.96 Mn |
| Mar 31, 2022 | 2.98 Mn |
| Dec 31, 2021 | 3.32 Mn |
| Sep 30, 2021 | 1.86 Mn |
API Access
Spyre Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();